BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for HARMONY BIOSCIENCES · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · $50,000.00 income · posted Jan 16, 2026

Lobbying activity 1

Health Issues

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tarrifs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.